Regulatory Open Forum

 View Only
  • 1.  FDA: Bundling Expedited pathways & Designations

    This message was posted by a user wishing to remain anonymous
    Posted 20-Feb-2024 09:09
    This message was posted by a user wishing to remain anonymous

    Hi all,

    Assumptions made:

    1. FDA alignment to seek accelerated approval.
    2. Evidence of effectiveness is shown in Ph 3 studies
    3. Meet criteria of serious conditions

    Is it possible to seek accelerated approval and request priority review for a NDA, at the same time?

    Thanks community!



  • 2.  RE: FDA: Bundling Expedited pathways & Designations

    Posted 20-Feb-2024 09:17
    Edited by Narayan Rao 20-Feb-2024 09:19

    Yes! Priority review is determined after you submit the application, 60 days from receipt date by the FDA.



    ------------------------------
    GRSAOnline
    ------------------------------



  • 3.  RE: FDA: Bundling Expedited pathways & Designations

    Posted 21-Feb-2024 04:02

    Generally, you will have FDA agreement on accelerated approval before submitting your NDA. Then in the NDA application you will state your request for accelerated approval and acceptance of the conditions of such. Priority review is determined by FDA at the time of filing of the NDA and would be generally assumed to granted for a filed NDA with the potential for accelerated approval.



    ------------------------------
    Glen Park PharmD
    Consultant
    Burien WA
    United States
    ------------------------------



  • 4.  RE: FDA: Bundling Expedited pathways & Designations

    This message was posted by a user wishing to remain anonymous
    Posted 21-Feb-2024 09:07
    This message was posted by a user wishing to remain anonymous

    Bottomline, yes, both accelerated approval and Priority review can be requested at the same time!